CERO THERAPEUTICS HOLDINGS, INC. Earnings Per Share, Basic and Diluted
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Earnings Per Share, Basic and Diluted of $0.00 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-19.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-19
- CERO THERAPEUTICS HOLDINGS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was $0.00.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 4 month |
|---|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-19 | $0.00 10-Q · filed 2021-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |